Veterinary Medicine Information website

NOBIVAC PUPPY DP

Not authorised
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine parvovirus, strain CPV 154, Live
Download as PDF

Product identification

Medicine name:
NOBIVAC PUPPY DP
Active substance:
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine parvovirus, strain CPV 154, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Onderstepoort, Live
    5.00
    log10 50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain CPV 154, Live
    8.00
    log10 50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Cyprus
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Ministry Of Agriculture Rural Development And Environment
Authorisation number:
  • 13214
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 25/08/2022
Download